We are absolutely thrilled to announce the distinguished presence of Dr. Sandy Qlintang dr Sandy Qlintang as a keynote speaker at #BioConAsia2023-ACGTConference! 🌟 Dr. Qlintang holds the esteemed title of Director of Stem Cell and Cancer Institute, and his presentation will revolve around the fascinating theme of "Optimization of Cell Therapy Development: Public and Private Synergy in Collaboration, Regulation, and Investment in Indonesia." 🧬 Dr. Sandy Qlintang brings a wealth of experience and expertise to the conference. He embarked on his journey with KALBE in 1999, and today, he stands at the helm of two of KALBE's renowned subsidiaries. Firstly, the Stem Cell and Cancer Institute, a significant contributor to KALBE's research initiatives, and secondly, Bifarma Adiluhung, a Stem Cell Manufacturer holds a GMP (Good Manufacturing Practice) certificate. 🏥🔬 #StemCellResearch #CancerInstitute His dedication to advancing science and research in Indonesia is underscored by his roles as a reviewer member in the Ministry of Research and Technology/National Research and Innovation Agency (Indonesia) since 2019 and his membership in the Consortium of Tissue Engineering and Stem Cells, Ministry of Health, since 2014. 📚🔍 #ResearchInnovation #Healthcare Dr. Qlintang's commitment extends further as a board member of the Association of Indonesia Tissue Engineering and Cell Therapy since 2016 and as a member of the Association of Indonesia's Stem Cells since 2020. 🌐🧪 #StemCellResearch #TissueEngineering In addition to his substantial contributions to the field, Dr. Sandy Qlintang has remained actively engaged in professional associations such as the Indonesia Medical Doctor Association and the Aesthetic and Anti-Aging Medicine Association since 2022. 💼💉 #MedicalAssociations #AntiAgingMedicine Don't miss this incredible opportunity to hear from a true luminary in the field! 🌐 For registration and further information, visit our conference website: https://lnkd.in/eqnkJcUh or contact bioconglobal@bmapglobal.com. Act fast and grab your early bird and group tickets now for a limited time! 🚀📈 #ScientificAdvancements #MedicalResearch